Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of ibuprofen + paracetamol + phenylephrine for temporary relief of cold and flu symptoms
2022-003559-32Phase 3Completed
- Sponsor
- PharOS
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen, acetaminophen and phenylephrine in nasopharyngitis and influenza (4 arms), sponsored by PharOS. Primary endpoint: Mean change of nasal airflow resistance. Started Jan 2023; status: completed.
02
Drugs
ibuprofenacetaminophenphenylephrine
03
Conditions
nasopharyngitisinfluenza
Beyond the preview
Go deeper on 2022-003559-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003559-32.